f-Met-Leu-Phe stimulates nitric oxide production in chick embryo neurons: The role of NF-κB

Immunopharmacology and Immunotoxicology

Volumn 31, Issue 1, 2009, Pages 51-63

  Cianciulli, Antonia ^a   Acquafredda, Angela ^a   Cavallo, Pasqua ^a   Saponaro, Concetta ^a   Calvello, Rosa ^a   Mitolo, Vincenzo ^a   Panaro, Maria Antonietta ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Chick embryo; fMLP; Neuron; NF B; Nitric oxide

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOSPORIN H; FORMYLMETHIONYLLEUCYLPHENYLALANINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PROTEIN BCL 2; PROTEIN BNIP3; SYNAPTOTAGMIN I; TOSYLPHENYLALANYL CHLOROMETHYL KETONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CHICK EMBRYO; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG INHIBITION; EMBRYO; EMBRYO CELL; IMMUNOCHEMISTRY; IN VITRO STUDY; NERVE CELL; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CELLS, CULTURED; CHICK EMBRYO; CYCLOSPORINE; ENZYME INHIBITORS; I-KAPPA B PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEURONS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-BCL-2; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRANSCRIPTION FACTOR RELA;

AVES; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 60749119221     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970802338799     Document Type: Article

References (41)

1. Marasco, W.A.; Phan, S.H.; Krutzsch, H.; Showell, H.J.; Feltner, D.E.; Nairn, R.; Becker, E.L.; Ward, P.A. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 1984; 259 (9):5430-5439.
2. Boulay, F.; Tardif, M.; Brouchon, L.; Vignais, P. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 1990; 29 (50):11123-11133.
3. Ali, H.; Haribabu, B.; Richardson, R.M.; Snyderman, R. Mechanisms of inflammation and leukocyte activation. Med. Clin. North Am. 1997; 81 (1):1-28.
4. Haviland, D.L.; Borel, A.C.; Fleischer, D.T.; Haviland, J.C.; Wetsel, R.A. Structure, 5′-flanking sequence, and chromosome location of the human N-formyl peptide receptor gene. A single-copy gene comprised of two exons on chromosome 19q.13.3 that yields two distinct transcripts by alternative polyadenylation. Biochemistry 1993; 32 (16):4168-4174.
5. Bockaert, J.; Pin, J.P. Molecular tinkering of G protein-coupled receptors: An evolutionary success. EMBO J. 1999; 18 (7):1723-1729.
6. Gudermann, T.; Kalkbrenner, F.; Dippel, E.; Laugwitz, K.L.; Schultz, G. Specificity and complexity of receptor-G-protein interaction. Adv. Second Messenger Phosphoprotein Res. 1997; 31:253-262.
7. Ye, R.D.; Quehenberger, O.; Thomas, K.M.; Navarro, J.; Cavanagh, S.L.; Prossnitz, E.R.; Cochrane, C.G. The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications. J. Immunol. 1993; 150 (4):1383-1394.
8. Gao, J.L.; Murphy, P.M. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. J. Biol. Chem. 1993; 268 (34): 25395-25401.
9. Alvarez, V.; Coto, E.; Setién, F.; González-Roces, S.; López-Larrea, C. Molecular evolution of the N-formyl peptide and C5a receptors in non-human primates. Immunogenetics 1996; 44 (6): 446-452.
10. Lacy, M.; Jones, J.; Whittemore, S.R.; Haviland, D.L.; Wetsel, R.A.; Barnum, S.R. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J.Neuroimmunol. 1995; 61 (1):71-78.
11. McCoy, R.; Haviland, D.L.; Molmenti, E.P.; Ziambaras, T.; Wetsel, R.A.; Perlmutter, D.H. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J. Exp. Med. 1995; 182 (1):207-217.
12. Becker, E.L.; Forouhar, F.A.; Grunnet, M.L.; Boulay, F.; Tardif, M.; Bormann, B.J.; Sodja, D.; Ye, R.D.; Woska, J.R. Jr.; Murphy, P.M. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells. Cell Tissue Res. 1998; 292 (1):129-135.
13. Panaro, M.A.; Mitolo, V. Cellular responses to FMLP challenging: A mini-review. Immunopharmacol. Immunotoxicol. 1999; 21 (3):397-419.
14. Le, Y.; Oppenheim, J.J.; Wang, J.M. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 2001; 12 (1):91-105.
15. Le, Y.; Murphy, P.M.; Wang, J.M. Formyl-peptide receptors revisited. Trends Immunol. 2002; 23 (11):541-548.
16. Panaro, M.A.; Acquafredda, A.; Sisto, M.; Lisi, S.; Maffione, A.B.; Mitolo, V. Biological role of the N-formyl peptide receptors. Immunopharmacol. Immunotoxicol. 2006; 28(1):103-127.
17. Panaro, M.A.; Cianciulli, A.; Lisi, S.; Sisto, M.; Acquafredda, A.; Mitolo, V. Formyl peptide receptor expression in birds. Immunopharmacol. Immunotoxicol. 2007; 29 (1):1-16.
18. Ding, A.H.; Nathan, C.F.; Stuehr, D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 1988; 141(7):2407-2412.
19. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72:248-254.
20. Vila-del Sol, V.; Díaz-Muñoz, M.D.; Fresno, M. Requirement of tumor necrosis factor alpha and nuclear factor-kappaB in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages. J. Leukoc. Biol. 2007; 81 (1):272-283.
21. Saluk-Juszczak, J.; Wachowicz, B. The proinflammatory activity of lipopolysaccharide. Postepy. Biochem. 2005; 51 (3):280-287.
22. Knowles, H.J.; Harris, A.L. Macrophages and the hypoxic tumour microenvironment. Front Biosci. 2007; 12:4298-4314.
23. Panaro, M.A.; Brandonisio, O.; Acquafredda, A.; Sisto, M.; Mitolo, V. Evidences for iNOS expression and nitric oxide production in the human macrophages. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2003; 3 (3):210-221.
24. Poluha, W.; Schonhoff, C.M.; Harrington, K.S.; Lachyankar, M.B.; Crosbie, N.E.; Bulseco, D.A.; Ross, A.H. A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAF1 regulates neuronal differentiation of PC12 cells. J. Biol. Chem. 1997; 272 (38):24002-24007.
25. Muñoz-Fernández, M.A.; Fresno, M. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 1998; 56 (3):307-340.
26. Jaken, S. Protein kinase C isozymes and substrates. Curr. Opin. Cell Biol. 1996; 8 (2):168-173.
27. Dekker, L.V.; Leitges, M.; Altschuler, G.; Mistry, N.; McDermott, A.; Roes, J.; Segal, AW. Protein kinase C-beta contributes to NADPH oxidase activation in neutrophils. Biochem. J. 2000; 347:285-289.
28. Spisani, S.; Falzarano, S.; Traniello, S.; Nalli, M.; Selvatici, R. A 'pure' chemoattractant formylpeptide analogue triggers a specific signaling pathway in human neutrophil chemotaxis. FEBS J. 2005; 272 (4):883-891.
29. Selvatici, R.; Falzarano, S.; Mollica, A.; Spisani, S. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur. J. Pharmacol. 2006; 534(1-3):1-11.
30. Pizzi, M.; Spano, P. Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms. Eur. J. Pharmacol. 2006; 545 (1):22-28.
31. Rao, K.M. Molecular mechanisms regulating iNOS expression in various cell types. J. Toxicol. Environ. Health B. Crit. Rev. 2000; 3(1): 27-58.
32. Browning, D.D.; Pan, Z.K.; Prossnitz, E.R.; Ye, R.D. Cell type- and developmental stage-specific activation of NF-kappaB by fMet-Leu-Phe in myeloid cells. J. Biol. Chem. 1997; 272 (12):7995-8001.
33. Heneka, M.T.; Feinstein, D.L. Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 2001; 114 (1-2):8-18.
34. Mémet, S. NF-kappaB functions in the nervous system: From development to disease. Biochem. Pharmacol. 2006; 72 (9):1180-1195.
35. Kleinert, H.; Schwarz, P.M.; Förstermann, U. Regulation of the expression of inducible nitric oxide synthase. Biol. Chem. 2003; 384 (10-11):1343-1364.
36. Kaltschmidt, B.; Widera, D.; Kaltschmidt, C. Signaling via NF-kappaB in the nervous system. Biochim. Biophys. Acta. 2005; 1745 (3):287-299.
37. Tomita, N.; Morishita, R.; Tomita, S.; Yamamoto, K.; Aoki, M.; Matsushita, H.; Hayashi, S.; Higaki, J.; Ogihara, T. Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells. J. Hypertens. 1998; 16:993-1000.
38. Camandola, S.; Mattson, M.P. Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression. J. Neurosci. Res. 2000; 61 (2):134-139.
39. Shou, Y.; Li, N.; Li, L.; Borowitz, J.L.; Isom, G.E. NF-kappaB-mediated up-regulation of Bcl-X(S) and Bax contributes to cytochrome c release in cyanide-induced apoptosis. J. Neurochem. 2002; 81 (4):842-852.
40. Mattson, M.P. NF-kappaB in the survival and plasticity of neurons. Neurochem. Res. 2005; 30 (6-7):883-893.
41. Mattson, M.P.; Culmsee, C.; Yu, Z.; Camandola, S. Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 2000; 74 (2):443-456.